Antares Pharma Inc. (ATRS)

3.10
0.04 1.30
NASDAQ : Health Technology
Prev Close 3.14
Open 3.14
Day Low/High 3.09 / 3.17
52 Wk Low/High 2.53 / 3.96
Volume 221.26K
Avg Volume 1.06M
Exchange NASDAQ
Shares Outstanding 163.06M
Market Cap 508.75M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Stocks Under $10 Weekly Summary

This week brings earnings from 5 portfolio holdings as the market continues to shrug off potential negatives.

Stocks Under $10 Weekly Summary

We took some profits and added a Bullpen name, among other moves, during a rough week for a few portfolio names.

How We're Playing AcelRx, Antares, AXI and Hudson Tech

Checking out some tough calls.

Stocks Under $10 Weekly Summary

We added to one name during a stellar week for the majority of the portfolio.

Recent Tech Big-Cap Laggards Finally Gain Some Attention

Recent Tech Big-Cap Laggards Finally Gain Some Attention

Money is flowing back into the FANG names and into Microsoft in particular while small-caps slow a bit.

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

Stocks Under $10 Weekly Summary

We took a healthy profit trimming one name and added to three other positions last week.

Stocks Under $10 Weekly Summary

We added a digital security name to the Bullpen during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated 2 new positions and jettisoned another over the last week.

Stocks Under $10 Weekly Summary

We remain cautious during this historically volatile month for the market.

Stocks Under $10 Weekly Summary

We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.

Stocks Under $10 Weekly Summary

We initiated 2 small positions last week as the market moved higher.

Commit To Purchase Antares Pharma At $2.50, Earn 42.4% Annualized Using Options

Commit To Purchase Antares Pharma At $2.50, Earn 42.4% Annualized Using Options

Investors considering a purchase of Antares Pharma Inc. shares, but tentative about paying the going market price of $3.06/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Stocks Under $10 Weekly Summary

We used last week's weakness to scale into several positions.

Stocks Under $10 Weekly Summary

North Korea puts a worrying wrinkle in the markets. We add to 2 portfolio positions.

Antares and Amplify Brands Reports; Plus Other Earnings News

Five portfolio names report today. Here is what we have seen, and what two expect after the closing bell.

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Revenue of $13.4 Million and Net Loss Per Share of $0.02

Stocks Under $10 Weekly Summary

It was a rough week for the portfolio.

Stocks Under $10 Weekly Summary

We made several trades and price target changes during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

TheStreet Quant Rating: C (Hold)